Glooko, a global digital health company, has raised $100M in a Series F funding round led by Georgian.
The funding will be used to drive product innovation and global expansion, focusing on advanced analytics, device integrations, clinical research, and chronic condition support.
Mike Alvarez has been appointed as the new Chief Executive Officer of Glooko, bringing over 20 years of leadership experience in the medical device and biotechnology industries.
Alvarez's expertise in global healthcare markets and digital health solutions will contribute to Glooko's growth and its mission to transform chronic condition management and improve clinical trials.